• Gingerenone A Re-sensitizes RCC to Sunitinib

  2026-08-11

  This January 2026 study identifies gingerenone A as an LDHA-directed metabolic inhibitor that suppresses glycolysis and restores sunitinib activity in renal cell carcinoma models. Its combination of target-discovery analysis, metabolic rescue experiments, drug-synergy testing, and in vivo validation supports glycolysis as a practical strategy for addressing TKI resistance.

• Oleanolic Acid in Dual-Loaded Liposome Workflows

  2026-08-11

  Learn how to handle Oleanolic acid as a DMSO-soluble triterpenoid and incorporate it into dual-loaded liposome research. A validated nanoparticle exclusion chromatography workflow helps distinguish free compound from encapsulated cargo when lipophilic and hydrophilic drugs are analyzed together.

• Deracoxib Workflows for COX-2 Research

  2026-08-10

  Build reproducible Deracoxib workflows for COX-2 inhibition, canine pain and inflammation research, and tumor-cell assays. This guide connects assay design with solvent handling, combination-treatment logic, translational limits, and practical troubleshooting.

• Spermine Tetrahydrochloride: From Charge to Translation

  2026-08-09

  A translational perspective on how spermine tetrahydrochloride connects membrane stabilization, protein crystallization, and ionic polyphosphazene formulation while defining the evidence boundaries for neuroscience and therapeutic research.

• Ertugliflozin (PF-04971729) Assay Guide

  2026-08-08

  A scenario-based guide to using Ertugliflozin (PF-04971729), SKU A3715, in cell viability, proliferation, cytotoxicity, and SGLT2-mediated glucose transport workflows. It covers assay interpretation, solvent compatibility, protocol controls, clinical evidence boundaries, and practical supplier-selection criteria.

• FXYD5 Downregulation Reverses Cisplatin Resistance

  2026-08-07

  The reference study identifies FXYD5 as a functional contributor to cisplatin resistance in epithelial ovarian cancer models rather than merely a prognostic correlate. Using MTT-derived IC50 measurements alongside proliferation, motility, invasion, apoptosis, qRT-PCR, and immunoblotting assays, the authors show that FXYD5 silencing resensitizes resistant cells while suppressing drug-efflux and epithelial–mesenchymal transition-associated features.

• Latrunculin B: Guiding High-Precision Actin Disruption Studi

  2026-08-07

  Explore Latrunculin B as a potent actin cytoskeleton inhibitor, with a focus on mechanistic insight, precise protocol parameters, and critical data for assay design. This analysis uniquely connects molecular action with real-world limitations to empower advanced cytoskeletal research.

• Intravesical p21 mRNA-LNPs: Advancing Localized Bladder Canc

  2026-08-06

  This study introduces a non-viral strategy using p21 mRNA-loaded lipid nanoparticles for localized intravesical therapy in bladder cancer, demonstrating significant tumor suppression and restored tumor suppressor function. The findings highlight the translational potential of mRNA delivery systems for targeted, minimally invasive cancer treatment.

• 6-FAM SE: Advanced Fluorescent Labeling for Reliable Molecul

  2026-08-06

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) offers unmatched stability, brightness, and amine reactivity for gene sequencing and protein labeling workflows. Its superior resistance to hydrolysis enables reproducible results even in demanding applications, bridging the gap between high-throughput molecular assays and innovative nanoparticle systems.

• Alisol A Regulates Cholesterol and Mitophagy in Vascular Cog

  2026-08-05

  This study reveals that Alisol A restores cognitive function in a vascular cognitive impairment (VCI) mouse model by activating the AMPK/NAMPT/SIRT1 axis, rebalancing cholesterol metabolism, and enhancing mitophagy. The mechanistic insights highlight NAMPT as a crucial target, presenting new avenues for addressing atherosclerosis-related cognitive decline.

• VE-821 ATR Kinase Inhibitor: Applied DDR Research Workflows

  2026-08-05

  VE-821 is a potent ATR kinase inhibitor that transforms DNA damage response research through its high selectivity and robust radiosensitization. This article provides expert-driven protocol strategies, advanced applications, and troubleshooting tips that help maximize the compound’s impact in DNA repair, epigenetic, and combination therapy studies.

• Wnt and BMP Pathways Shape Neuroectoderm in Hemichordate Dev

  2026-08-04

  This study systematically maps the spatial and functional roles of Wnt and BMP signaling in anterior neuroectoderm (ANE) patterning during gastrulation of the indirect-developing hemichordate Ptychodera flava. Its findings clarify evolutionary conservation and divergence of axis-patterning mechanisms in deuterostomes, with direct relevance for developmental biology and Wnt pathway modulation workflows.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-08-04

  DiI (DiIC18(3)) provides robust, high-contrast labeling of plasma membranes in both live and fixed cells, supporting applications such as neuronal tracing and cell migration assays. It is not suitable for aqueous-only protocols or for labeling intracellular organelles. Proper solvent use and workflow adherence are critical to maintain specificity and fluorescence intensity.

• D-N-Acetylgalactosamine: Technical Guidance for Glycoprotein

  2026-08-03

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for biochemical and neurological research, particularly in the structural analysis of brain glycoproteins and glycosylation pathways. It is not suitable for workflows requiring ethanol solubility or long-term storage of prepared solutions, and strict adherence to handling protocols is necessary to maintain reproducibility.

• Irisin Preserves Mitochondrial Function in Renal I/R Injury

  2026-08-03

  The referenced study demonstrates that irisin, a myokine released during exercise, preserves mitochondrial integrity and function in tubular epithelial cells following ischemia–reperfusion-induced acute kidney injury (AKI). By dissecting the molecular mechanisms and using a rigorous in vivo and ex vivo approach, the authors reveal irisin’s capacity to modulate mitochondrial autophagy pathways, providing new insight into AKI pathophysiology and potential intervention strategies.

16687 records 1/1113 page Next 12345 下5页 Last page